232 tariffs may make pharmaceutical onshoring more difficult, industry rep says
The Section 232 tariffs on steel and aluminum, along with a slew of other potential 232 tariffs, may make moving manufacturing to the US more difficult, a US pharmaceutical industry rep...To view the full article, register now.
Already a subscriber? Click here to view full article